Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.08
MLAB's Cash to Debt is ranked lower than
94% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. MLAB: 0.08 )
Ranked among companies with meaningful Cash to Debt only.
MLAB' s 10-Year Cash to Debt Range
Min: 0.08  Med: 10000.00 Max: No Debt
Current: 0.08
Equity to Asset 0.63
MLAB's Equity to Asset is ranked higher than
59% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. MLAB: 0.63 )
Ranked among companies with meaningful Equity to Asset only.
MLAB' s 10-Year Equity to Asset Range
Min: 0.63  Med: 0.93 Max: 0.96
Current: 0.63
0.63
0.96
F-Score: 6
Z-Score: 7.36
M-Score: -2.31
WACC vs ROIC
10.07%
10.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 22.24
MLAB's Operating margin (%) is ranked higher than
88% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.42 vs. MLAB: 22.24 )
Ranked among companies with meaningful Operating margin (%) only.
MLAB' s 10-Year Operating margin (%) Range
Min: 22.24  Med: 32.85 Max: 38.27
Current: 22.24
22.24
38.27
Net-margin (%) 13.43
MLAB's Net-margin (%) is ranked higher than
80% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.58 vs. MLAB: 13.43 )
Ranked among companies with meaningful Net-margin (%) only.
MLAB' s 10-Year Net-margin (%) Range
Min: 13.43  Med: 22.35 Max: 25.93
Current: 13.43
13.43
25.93
ROE (%) 13.87
MLAB's ROE (%) is ranked higher than
74% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.05 vs. MLAB: 13.87 )
Ranked among companies with meaningful ROE (%) only.
MLAB' s 10-Year ROE (%) Range
Min: 13.91  Med: 17.48 Max: 22.21
Current: 13.87
13.91
22.21
ROA (%) 8.66
MLAB's ROA (%) is ranked higher than
77% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. MLAB: 8.66 )
Ranked among companies with meaningful ROA (%) only.
MLAB' s 10-Year ROA (%) Range
Min: 8.92  Med: 15.08 Max: 20.4
Current: 8.66
8.92
20.4
ROC (Joel Greenblatt) (%) 66.20
MLAB's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.82 vs. MLAB: 66.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MLAB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 47.2  Med: 67.87 Max: 106.38
Current: 66.2
47.2
106.38
Revenue Growth (3Y)(%) 19.50
MLAB's Revenue Growth (3Y)(%) is ranked higher than
91% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. MLAB: 19.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MLAB' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1.2  Med: 11.30 Max: 24.7
Current: 19.5
1.2
24.7
EBITDA Growth (3Y)(%) 11.60
MLAB's EBITDA Growth (3Y)(%) is ranked higher than
62% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. MLAB: 11.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MLAB' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 4.1  Med: 11.30 Max: 27.8
Current: 11.6
4.1
27.8
EPS Growth (3Y)(%) 4.70
MLAB's EPS Growth (3Y)(%) is ranked higher than
52% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. MLAB: 4.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MLAB' s 10-Year EPS Growth (3Y)(%) Range
Min: 0.7  Med: 10.60 Max: 24
Current: 4.7
0.7
24
» MLAB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MLAB Guru Trades in Q3 2014

Jim Simons 167,800 sh (+4.48%)
Chuck Royce 52,589 sh (unchged)
» More
Q4 2014

MLAB Guru Trades in Q4 2014

Jim Simons 147,224 sh (-12.26%)
Chuck Royce 42,789 sh (-18.64%)
» More
Q1 2015

MLAB Guru Trades in Q1 2015

Jim Simons 140,100 sh (-4.84%)
Chuck Royce 38,489 sh (-10.05%)
» More
Q2 2015

MLAB Guru Trades in Q2 2015

Arnold Van Den Berg 5,538 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 44.70
MLAB's P/E(ttm) is ranked lower than
64% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.20 vs. MLAB: 44.70 )
Ranked among companies with meaningful P/E(ttm) only.
MLAB' s 10-Year P/E(ttm) Range
Min: 10.38  Med: 17.64 Max: 44.7
Current: 44.7
10.38
44.7
Forward P/E 22.94
MLAB's Forward P/E is ranked lower than
55% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.03 vs. MLAB: 22.94 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 42.90
MLAB's PE(NRI) is ranked lower than
67% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.60 vs. MLAB: 42.90 )
Ranked among companies with meaningful PE(NRI) only.
MLAB' s 10-Year PE(NRI) Range
Min: 10.41  Med: 17.57 Max: 42.27
Current: 42.9
10.41
42.27
P/B 5.68
MLAB's P/B is ranked lower than
72% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. MLAB: 5.68 )
Ranked among companies with meaningful P/B only.
MLAB' s 10-Year P/B Range
Min: 1.78  Med: 2.96 Max: 5.68
Current: 5.68
1.78
5.68
P/S 6.13
MLAB's P/S is ranked lower than
70% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.84 vs. MLAB: 6.13 )
Ranked among companies with meaningful P/S only.
MLAB' s 10-Year P/S Range
Min: 2.32  Med: 3.89 Max: 6.86
Current: 6.13
2.32
6.86
PFCF 53.55
MLAB's PFCF is ranked lower than
71% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.29 vs. MLAB: 53.55 )
Ranked among companies with meaningful PFCF only.
MLAB' s 10-Year PFCF Range
Min: 11.62  Med: 21.83 Max: 350
Current: 53.55
11.62
350
POCF 39.49
MLAB's POCF is ranked lower than
75% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.15 vs. MLAB: 39.49 )
Ranked among companies with meaningful POCF only.
MLAB' s 10-Year POCF Range
Min: 9.94  Med: 15.42 Max: 39.49
Current: 39.49
9.94
39.49
EV-to-EBIT 27.99
MLAB's EV-to-EBIT is ranked lower than
59% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.59 vs. MLAB: 27.99 )
Ranked among companies with meaningful EV-to-EBIT only.
MLAB' s 10-Year EV-to-EBIT Range
Min: 5.3  Med: 10.80 Max: 30.3
Current: 27.99
5.3
30.3
PEG 2.77
MLAB's PEG is ranked higher than
60% of the 65 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. MLAB: 2.77 )
Ranked among companies with meaningful PEG only.
MLAB' s 10-Year PEG Range
Min: 0.43  Med: 1.30 Max: 3.42
Current: 2.77
0.43
3.42
Shiller P/E 51.80
MLAB's Shiller P/E is ranked lower than
73% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.99 vs. MLAB: 51.80 )
Ranked among companies with meaningful Shiller P/E only.
MLAB' s 10-Year Shiller P/E Range
Min: 13.63  Med: 22.39 Max: 51.8
Current: 51.8
13.63
51.8
Current Ratio 2.02
MLAB's Current Ratio is ranked lower than
59% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. MLAB: 2.02 )
Ranked among companies with meaningful Current Ratio only.
MLAB' s 10-Year Current Ratio Range
Min: 1.74  Med: 9.28 Max: 18.4
Current: 2.02
1.74
18.4
Quick Ratio 1.17
MLAB's Quick Ratio is ranked lower than
66% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. MLAB: 1.17 )
Ranked among companies with meaningful Quick Ratio only.
MLAB' s 10-Year Quick Ratio Range
Min: 1.16  Med: 6.90 Max: 14.6
Current: 1.17
1.16
14.6
Days Inventory 139.45
MLAB's Days Inventory is ranked lower than
55% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 129.36 vs. MLAB: 139.45 )
Ranked among companies with meaningful Days Inventory only.
MLAB' s 10-Year Days Inventory Range
Min: 104  Med: 199.31 Max: 284.7
Current: 139.45
104
284.7
Days Sales Outstanding 62.15
MLAB's Days Sales Outstanding is ranked higher than
51% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.83 vs. MLAB: 62.15 )
Ranked among companies with meaningful Days Sales Outstanding only.
MLAB' s 10-Year Days Sales Outstanding Range
Min: 59.76  Med: 74.98 Max: 131.8
Current: 62.15
59.76
131.8

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.53
MLAB's Dividend Yield is ranked lower than
78% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. MLAB: 0.53 )
Ranked among companies with meaningful Dividend Yield only.
MLAB' s 10-Year Dividend Yield Range
Min: 0.52  Med: 1.52 Max: 2.6
Current: 0.53
0.52
2.6
Dividend Payout 0.24
MLAB's Dividend Payout is ranked higher than
76% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. MLAB: 0.24 )
Ranked among companies with meaningful Dividend Payout only.
MLAB' s 10-Year Dividend Payout Range
Min: 0.15  Med: 0.25 Max: 0.3
Current: 0.24
0.15
0.3
Dividend growth (3y) 7.40
MLAB's Dividend growth (3y) is ranked lower than
57% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. MLAB: 7.40 )
Ranked among companies with meaningful Dividend growth (3y) only.
MLAB' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 7.40 Max: 44.2
Current: 7.4
0
44.2
Yield on cost (5-Year) 0.77
MLAB's Yield on cost (5-Year) is ranked lower than
75% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.65 vs. MLAB: 0.77 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MLAB' s 10-Year Yield on cost (5-Year) Range
Min: 0.89  Med: 2.24 Max: 3.84
Current: 0.77
0.89
3.84
Share Buyback Rate -1.80
MLAB's Share Buyback Rate is ranked higher than
54% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. MLAB: -1.80 )
Ranked among companies with meaningful Share Buyback Rate only.
MLAB' s 10-Year Share Buyback Rate Range
Min: 6.1  Med: -0.50 Max: -2.9
Current: -1.8

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.47
MLAB's Price/Projected FCF is ranked lower than
62% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. MLAB: 2.47 )
Ranked among companies with meaningful Price/Projected FCF only.
MLAB' s 10-Year Price/Projected FCF Range
Min: 0.72  Med: 1.26 Max: 2.11
Current: 2.47
0.72
2.11
Price/DCF (Earnings Based) 2.37
MLAB's Price/DCF (Earnings Based) is ranked lower than
61% of the 18 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. MLAB: 2.37 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.57
MLAB's Price/Median PS Value is ranked lower than
57% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. MLAB: 1.57 )
Ranked among companies with meaningful Price/Median PS Value only.
MLAB' s 10-Year Price/Median PS Value Range
Min: 0.49  Med: 0.89 Max: 1.59
Current: 1.57
0.49
1.59
Price/Peter Lynch Fair Value 3.53
MLAB's Price/Peter Lynch Fair Value is ranked lower than
73% of the 41 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.98 vs. MLAB: 3.53 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MLAB' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.45  Med: 1.26 Max: 3.37
Current: 3.53
0.45
3.37
Earnings Yield (Greenblatt) (%) 3.55
MLAB's Earnings Yield (Greenblatt) (%) is ranked higher than
61% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. MLAB: 3.55 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MLAB' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.3  Med: 9.30 Max: 18.7
Current: 3.55
3.3
18.7
Forward Rate of Return (Yacktman) (%) 15.34
MLAB's Forward Rate of Return (Yacktman) (%) is ranked higher than
66% of the 88 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.94 vs. MLAB: 15.34 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MLAB' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 9.8  Med: 18.80 Max: 29.6
Current: 15.34
9.8
29.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Mesa Laboratories Inc was incorporated under the laws of the State of Colorado on March 26, 1982. The Company is focused on quality control products, which are sold into niche markets that are driven by regulatory requirements. It is organized into three divisions across six physical locations. Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments. The Lakewood, Colorado, and Butler, New Jersey, facilities manufacture Instruments Division products which include the DataTrace, DialyGuard, DryCal, Torqo, SureTorque and BGI brands. The Omaha, Nebraska, and Bozeman, Montana locations manufacture Biological Indicators Division products which include the Mesa, PCD and Apex brands, while the Lakewood, Colorado, facility also manufactures Continuous Monitoring Division products which include CheckPoint and AmegaView brands. Companies with which Instruments Division products compete include the Myron L Company, IBP Medical GmbH, Amphenol Corporation, Ellab, TMI Orion, Danaher, Inc., Thermo Fisher Scientific, Inc., Mecmesin, Steinfurth, Met One Instruments, Inc. and Tisch Environmental. Biological Indicators Division products compete with 3M, Terragene, NAMSA and Steris, among others. Continuous Monitoring Division systems compete with Rees Scientific Corporation, Amphenol Corporation and Cooper-Atkins, among others. Several products in both the Instruments and Biological Indicators Divisions are medical devices subject to the provisions of the Federal Food, Drug and Cosmetic Act, as amended by the Medical Device Amendments of 1976.
» More Articles for MLAB

Headlines

Articles On GuruFocus.com
Van Den Berg Adds Four Stakes to Portfolio in Second Quarter Jul 14 2015 
Mesa Laboratories Inc. (MLAB) CFO, Secretary Steven W Peterson sells 10,000 Shares Mar 03 2011 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 16 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Labs Reports Higher First Quarter Earnings Aug 11 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 13 2009 

More From Other Websites
Mesa Labs Reports 23 Percent Increase in First Quarter Net Income Aug 03 2015
Mesa Labs posts 1Q profit Aug 03 2015
Mesa Labs posts 1Q profit Aug 03 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Aug 03 2015
Mesa Labs Reports 23 Percent Increase in First Quarter Net Income Aug 03 2015
Mesa Labs Announces New Suite of Validation Services Jul 16 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 15 2015
Van Den Berg Adds Four Stakes to Portfolio in Second Quarter Jul 14 2015
Mesa Labs Declares Quarterly Dividend Jul 08 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 07 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Jul 06 2015
Mesa Labs Acquires Canada’s Infitrak Inc. Jul 06 2015
Mesa Labs Acquires Canada's Infitrak Inc. Jul 06 2015
MESA LABORATORIES INC /CO Financials Jun 06 2015
10-K for Mesa Laboratories, Inc. Jun 05 2015
MESA LABORATORIES INC /CO Files SEC form 10-K, Annual Report Jun 03 2015
Mesa Labs Reports Record Net Income and Revenues Jun 01 2015
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Jun 01 2015
Mesa Labs posts 4Q profit Jun 01 2015
Mesa Labs posts 4Q profit Jun 01 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK